Lower-dose gadolinium now being used for MRIs with contrast – Multiple Sclerosis News Today
Columnist Ed Tobias wonders how the new gadolinium-based contrast agent Elucirem will affect patients' comfort levels during MRIs.
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Columnist Ed Tobias wonders how the new gadolinium-based contrast agent Elucirem will affect patients' comfort levels during MRIs.
Columnist Ed Tobias wonders how the new gadolinium-based contrast agent Elucirem will affect patients' comfort levels during MRIs.
No cure exists yet for multiple sclerosis, but there are several treatment options that can help manage MS symptoms, progression, and attacks.
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - read this article along with other careers information, tips and advice on BioSpace
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...